StockData

China SXT Pharmaceuticals, Inc. (SXTC) stock

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$2.86−0.13 (-4.35%)

Close on Nov 17, 2026Market cap $2.74MP/E –Yield –

China SXT Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for China SXT Pharmaceuticals

China SXT Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More China SXT Pharmaceuticals figures

See a number that looks wrong?